DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

Nature Genetics

Volumn 33, Issue 1, 2003, Pages 61-65

  Robert, Marie France ^a   Morin, Steves ^a   Beaulieu, Normand ^a   Gauthier, France ^a   Chute, Ian C ^a   Barsalou, Annie ^a   MacLeod, A Robert ^a  

^a MethylGene ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE;

ALLELE; ARTICLE; BLADDER CANCER; CANCER CELL; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; ENZYME ACTIVITY; GENE ACTIVATION; GENE DISRUPTION; GENE FUNCTION; GENE INACTIVATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DEPLETION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, P16; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037224722     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1068     Document Type: Article

References (30)

1. Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 (2002).
2. Esteller, M. & Herman, J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 196, 1-7 (2002).
3. Rountree, M.R., Bachman, K.E., Herman, J.G. & Baylin, S.B. DNA methylation, chromatin inheritance, and cancer. Oncogene 20, 3156-3165 (2001).
4. Robertson, K.D. DNA methylation, methyltransferases, and cancer. Oncogene 20, 3139-3155 (2001).
5. Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926 (1992).
6. Laird, P.W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197-205 (1995).
7. Fournel, M., Sapieha, P., Beaulieu, N., Besterman, J.M. & MacLeod, A.R. Downregulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J. Biol. Chem. 274, 24250-24256 (1999).
8. Rhee, I. et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003-1007 (2000).
9. Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552-556 (2002).
10. Beaulieu, N. et al. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J. Biol. Chem. 277, 28176-28181 (2002).
11. Okano, M., Bell, D.W., Haber, D.A. & Li, E. DNA methyltransferases DNMT3a and DNMT3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999).
12. Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362-365 (1993).
13. Yoder, J.A., Soman, N.S., Verdine, G.L. & Bestor, T.H. DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J. Mol. Biol. 270, 385-395 (1997).
14. Gonzalez-Zulueta, M. et al. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55, 4531-4535 (1995).
15. Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med. 1, 633-634 (1995).
16. Myohanen, S.K., Baylin, S.B. & Herman, J.G. Hypermethylation can selectively silence individual CDKN2A alleles in neoplasia. Cancer Res. 58, 591-593 (1998).
17. Herman, J.G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95, 6870-6875 (1999).
18. Kane, M.F. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808-811 (1997).
19. Leung, S.Y. et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59, 159-164 (1999).
20. Pogribny, I., Yi, P. & James, S.J. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262, 624-628 (1999).
21. Jutterman, R., Li, E. & Jaenisch, R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 981, 11797 (1994).
22. Christman, J.K., Schneiderman, N. & Acs, G. Formation of highly stable complexes between 5-azacytosine-tosine-substituted DNA and specific non-histone nuclear proteins. Implications for 5-azacytidine-mediated effects on DNA methylation and gene expression. J. Biol. Chem. 260, 4059-4068 (1985).
23. Haaf, T. & Schmid, M. 5′-Azadeoxycytidine-induced undercondensation in the giant X chromosomes of Microtus agrestis. Chromosoma 98, 93-98 (1989).
24. Haaf, T. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: Implications for methylation-associated cellular processes. Pharmacol. Ther. 65, 19-46 (1995).
25. Liang, G. et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell Biol. 22, 480-491 (2002).
26. Jonkers, J. & Berns, A. Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2, 251-265 (2002).
27. Bachman, K.E., Rountree, M.R. & Baylin, S.B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem, 276, 32282-32287 (2001).
28. Margot, J.B., Cardoso, M.C. & Leonhardt. H. Mammalian DNA methyltransferases show different subnuclear distributions. J. Cell. Biochem. 83, 373-379 (2001).
29. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826 (1996).
30. Agathanggelou, A. et al. Methylation-associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 20, 1509-1518 (2001).